Egypt’s Amreyah Pharmaceuticals recorded a net profit of 59.2 million Egyptian pounds ($9.5 million) for 2003 compared to EP 43.3 million in 2002, according to a company statement.
Founded in 1984, Amreyah produces and exports 85 types of pharmaceuticals for human and veterinary use. Its shares are 23 percent held by Arab investors, 18 percent by pharmaceutical company Rhone Poulenc, 15 percent by Abd El-Aziz Daghestany, 16.5 percent by CIIC, five percent each by Synthelabo and Alexandria Maritime Bank with the remaining 17.5 percent held by individual stockholders. — (menareport.com)
© 2004 Mena Report (www.menareport.com)
